SAN DIEGO, April 24, 2012 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) today announced it will report results for its first quarter ended March 31, 2012 after the market closes on Tuesday, May 1, 2012.
Alan D. Gold, Chairman and Chief Executive Officer, Kent Griffin, President, Matt McDevitt, Executive Vice President, and Greg N. Lubushkin, Chief Financial Officer, will host an investor conference call at 10:00 a.m. Pacific Time on Wednesday, May 2, 2012 to discuss the company's financial results and operations for the quarter.
The call will be open to all interested investors either through a live audio web cast at the Investor Relations section of the company's web site at www.biomedrealty.com and at www.earnings.com, which will include an online slide presentation to accompany the call, or live by calling (800) 901-5218 (domestic) or (617) 786-4511 (international) with call ID number 16757963. The complete webcast will be archived for 30 days on both web sites. A telephone playback of the conference call will also be available from 1:00 p.m. Pacific Time on Wednesday, May 2, 2012 until midnight Pacific Time on Monday, May 7, 2012 by calling (888) 286-8010 (domestic) or (617) 801-6888 (international) and using access code 90031220.
About BioMed Realty Trust
BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry®. The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed owns or has interests in properties comprising approximately 12.7 million rentable square feet. The company's properties are located predominantly in the major U.S. life science markets of Boston, San Francisco, San Diego, Maryland, New York/New Jersey, Pennsylvania and Seattle, which have well-established reputations as centers for scientific research. Additional information is available at www.biomedrealty.com.
SOURCE BioMed Realty Trust, Inc.